Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
February 22 2013 - 2:10PM
Edgar (US Regulatory)
|
|
|
|
|
OMB
APPROVAL
|
OMB Number:
|
|
3235-0167
|
Expires:
|
|
December 31, 2014
|
Estimated average burden
|
hours per response
|
|
1.50
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
1-32186
YM
BIOSCIENCES INC.
(Exact name of registrant as specified in its charter)
Suite 400, Building 11
5045 Orbiter Drive
Mississauga, Ontario
Canada L4W 4Y4
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Shares, without nominal or par value per share
(Title of each
class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file
reports:
|
|
|
Rule 12g-4(a)(1)
|
|
x
|
Rule 12g-4(a)(2)
|
|
¨
|
Rule 12h-3(b)(1)(i)
|
|
x
|
Rule 12h-3(b)(1)(ii)
|
|
¨
|
Rule 15d-6
|
|
¨
|
Approximate number of holders of record as of the certification or notice date:
One (1)
Pursuant to the requirements of the Securities Exchange Act of 1934, YM BioSciences Inc. has caused this certification/notice
to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date:
February 22, 2013
|
|
|
|
By:
|
|
/s/ Brett A. Pletcher
|
|
|
|
|
|
|
Name: Brett A. Pletcher
Title: President
|
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the
Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The
name and title of the person signing the form shall be typed or printed under the signature.
|
|
|
SEC 2069 (02-08)
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control
number.
|
YM Biosciences (AMEX:YMI)
Historical Stock Chart
From Sep 2024 to Oct 2024
YM Biosciences (AMEX:YMI)
Historical Stock Chart
From Oct 2023 to Oct 2024